Are HeartSciences Inc. (NASDAQ: HSCS) Shares Ready For A Higher Price Run?

In the last trading session, 1.56 million shares of the HeartSciences Inc. (NASDAQ:HSCS) were traded, and its beta was 3.44. Most recently the company’s share price was $0.10, and it changed around -$0.01 or -6.09% from the last close, which brings the market valuation of the company to $6.87M. HSCS currently trades at a discount to its 52-week high of $1.49, offering almost -1390.0% off that amount. The share price’s 52-week low was $0.11, which indicates that the current value has fallen by an impressive -10.0% since then. We note from HeartSciences Inc.’s average daily trading volume that its 10-day average is 1.04 million shares, with the 3-month average coming to 2.83 million.

HeartSciences Inc. (NASDAQ:HSCS) trade information

Instantly HSCS has showed a red trend with a performance of -6.09% at the end of last trading. The performance over the last five days has remained in the red territory. The company’s shares are currently down -38.71% year-to-date, but still down -12.67% over the last five days. On the other hand, HeartSciences Inc. (NASDAQ:HSCS) is -13.67% down in the 30-day period. We can see from the shorts that 0.51 million shares have been sold at a short interest cover period of 0.26 day(s).

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The consensus price target as assigned by Wall Street analysts is $3, which translates to bulls needing to increase their stock price by 96.67% from its current value. Analyst projections state that HSCS is forecast to be at a low of $3 and a high of $3.

HeartSciences Inc. (HSCS) estimates and forecasts

Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 85.70% in revenue this quarter, and will report an increase of 76.90% in the next quarter. The year-over-year growth rate is expected to be 1,100.00%, up from the previous year.

Consensus estimates provided by 2 financial analysts predict the company will bring in an average of $50k in revenue for the current quarter. 2 analysts expect HeartSciences Inc. to make $200k in revenue for the quarter ending Jul 2024.

HSCS Dividends

HeartSciences Inc.’s next quarterly earnings report is expected to be released in May.

HeartSciences Inc. (NASDAQ:HSCS)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 16.01% of HeartSciences Inc. shares, and 1.84% of them are in the hands of institutional investors. The stock currently has a share float of 2.19%. HeartSciences Inc. stock is held by 19 institutions, with Tradition Wealth Management, LLC being the largest institutional investor. By Jun 29, 2023, it held 1.36% of the shares, which is about 0.15 million shares worth $0.13 million.

Oliver Lagore Vanvalin Investment Group, with 1.03% or 0.11 million shares worth $0.1 million as of Jun 29, 2023, holds the second largest percentage of outstanding shares.